Cargando…
Impact of COVID-19 pneumonia on pulmonary vascular volume
BACKGROUND: Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dy...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073514/ https://www.ncbi.nlm.nih.gov/pubmed/37035332 http://dx.doi.org/10.3389/fmed.2023.1117151 |
_version_ | 1785019584875593728 |
---|---|
author | Fahrni, Guillaume Rocha, Ana-Carolina Gudmundsson, Louis Pozzessere, Chiara Qanadli, Salah D. Rotzinger, David C. |
author_facet | Fahrni, Guillaume Rocha, Ana-Carolina Gudmundsson, Louis Pozzessere, Chiara Qanadli, Salah D. Rotzinger, David C. |
author_sort | Fahrni, Guillaume |
collection | PubMed |
description | BACKGROUND: Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dysregulation as a contributing factor. In this study, we aim to better describe the changes in vascular volume in affected lung zones and to relate them to pathophysiological hypotheses. METHODS: We performed automatic vascular volume extraction in 10 chest CTs of patients, including 2 female and 8 male with a mean age of 63.5 ± 9.3 years, diagnosed with COVID-19 pneumonia. We compared the proportion of vascular volumes between manually segmented regions of lung parenchyma with and without signs of pneumonia. RESULTS: The proportion of vascular volume was significantly higher in COVID (CVasc) compared to non-COVID (NCVasc) areas. We found a mean difference (DVasc) of 5% and a mean ratio (RVasc) of 3.7 between the two compartments (p < 0.01). CONCLUSION: Vascular volume in COVID-19 affected lung parenchyma is augmented relative to normal lung parenchyma, indicating venous congestion and supporting the hypothesis of pre-existing intra-pulmonary arteriovenous shunts. |
format | Online Article Text |
id | pubmed-10073514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100735142023-04-06 Impact of COVID-19 pneumonia on pulmonary vascular volume Fahrni, Guillaume Rocha, Ana-Carolina Gudmundsson, Louis Pozzessere, Chiara Qanadli, Salah D. Rotzinger, David C. Front Med (Lausanne) Medicine BACKGROUND: Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dysregulation as a contributing factor. In this study, we aim to better describe the changes in vascular volume in affected lung zones and to relate them to pathophysiological hypotheses. METHODS: We performed automatic vascular volume extraction in 10 chest CTs of patients, including 2 female and 8 male with a mean age of 63.5 ± 9.3 years, diagnosed with COVID-19 pneumonia. We compared the proportion of vascular volumes between manually segmented regions of lung parenchyma with and without signs of pneumonia. RESULTS: The proportion of vascular volume was significantly higher in COVID (CVasc) compared to non-COVID (NCVasc) areas. We found a mean difference (DVasc) of 5% and a mean ratio (RVasc) of 3.7 between the two compartments (p < 0.01). CONCLUSION: Vascular volume in COVID-19 affected lung parenchyma is augmented relative to normal lung parenchyma, indicating venous congestion and supporting the hypothesis of pre-existing intra-pulmonary arteriovenous shunts. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073514/ /pubmed/37035332 http://dx.doi.org/10.3389/fmed.2023.1117151 Text en Copyright © 2023 Fahrni, Rocha, Gudmundsson, Pozzessere, Qanadli and Rotzinger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Fahrni, Guillaume Rocha, Ana-Carolina Gudmundsson, Louis Pozzessere, Chiara Qanadli, Salah D. Rotzinger, David C. Impact of COVID-19 pneumonia on pulmonary vascular volume |
title | Impact of COVID-19 pneumonia on pulmonary vascular volume |
title_full | Impact of COVID-19 pneumonia on pulmonary vascular volume |
title_fullStr | Impact of COVID-19 pneumonia on pulmonary vascular volume |
title_full_unstemmed | Impact of COVID-19 pneumonia on pulmonary vascular volume |
title_short | Impact of COVID-19 pneumonia on pulmonary vascular volume |
title_sort | impact of covid-19 pneumonia on pulmonary vascular volume |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073514/ https://www.ncbi.nlm.nih.gov/pubmed/37035332 http://dx.doi.org/10.3389/fmed.2023.1117151 |
work_keys_str_mv | AT fahrniguillaume impactofcovid19pneumoniaonpulmonaryvascularvolume AT rochaanacarolina impactofcovid19pneumoniaonpulmonaryvascularvolume AT gudmundssonlouis impactofcovid19pneumoniaonpulmonaryvascularvolume AT pozzesserechiara impactofcovid19pneumoniaonpulmonaryvascularvolume AT qanadlisalahd impactofcovid19pneumoniaonpulmonaryvascularvolume AT rotzingerdavidc impactofcovid19pneumoniaonpulmonaryvascularvolume |